Okay Pharmaceutical Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 210

Employees

  • Stock Symbol
  • 920230

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $1.27
  • (As of Friday Closing)

Okay Pharmaceutical General Information

Description

Chengdu Okay Pharmaceutical Co Ltd engages in research and development, production, and sales of plant extracts. It specializes in natural vitamin P products, including large-scale professional planting, extraction, purification, synthesis, and application. Its product series include Citrus Extract Series, Sophorae Japonica Series, and Miscellaneous Extract Series.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Number 15, Chuangye Road, Linqiong Industrial Park
  • Qionglai
  • Chengdu, Sichuan 611530
  • China
+86 028
Primary Industry
Specialty Chemicals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
BJSE
Vertical(s)
Corporate Office
  • Number 15, Chuangye Road, Linqiong Industrial Park
  • Qionglai
  • Chengdu, Sichuan 611530
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Okay Pharmaceutical Stock Performance

As of 20-Nov-2026, Okay Pharmaceutical’s stock price is $1.27. Its current market cap is $127M with 100M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.27 $1.33 $1.25 - $2.52 $127M 100M 1.53M $0.02

Okay Pharmaceutical Financials Summary

As of 30-Sep-2026, Okay Pharmaceutical has a trailing 12-month revenue of $46.9M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 166,751 170,445 144,023 133,806
Revenue 46,907 46,130 43,240 34,320
EBITDA 2,421 4,822 4,884 2,939
Net Income 2,177 1,598 3,128 2,356
Total Assets 76,346 75,976 72,494 63,919
Total Debt 3,087 3,128 2,842 2,986
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Okay Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Okay Pharmaceutical‘s full profile, request access.

Request a free trial

Okay Pharmaceutical Patents

Okay Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2909313-T3 Diosmin preparation method Active 30-Aug-2016
EP-3321273-A1 Preparation method of diosmin Active 30-Aug-2016
EP-3321273-A4 Preparation method of diosmin Active 30-Aug-2016
EP-3321273-B1 Preparation method of diosmin Active 30-Aug-2016
WO-2018039923-A1 Preparation method of diosmin Inactive 30-Aug-2016 C07H1/00
To view Okay Pharmaceutical’s complete patent history, request access »

Okay Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Okay Pharmaceutical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Okay Pharmaceutical‘s full profile, request access.

Request a free trial

Okay Pharmaceutical Acquisitions (1)

Okay Pharmaceutical’s most recent deal was a Merger/Acquisition with Medicui for . The deal was made on 01-Dec-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Medicui 01-Dec-2021 Merger/Acquisition Biotechnology
To view Okay Pharmaceutical’s complete acquisitions history, request access »

Okay Pharmaceutical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Okay Pharmaceutical’s complete esg history, request access »

Okay Pharmaceutical Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Medicui Qionglai, China 2019

Okay Pharmaceutical FAQs

  • When was Okay Pharmaceutical founded?

    Okay Pharmaceutical was founded in 2010.

  • Where is Okay Pharmaceutical headquartered?

    Okay Pharmaceutical is headquartered in Chengdu, China.

  • What is the size of Okay Pharmaceutical?

    Okay Pharmaceutical has 210 total employees.

  • What industry is Okay Pharmaceutical in?

    Okay Pharmaceutical’s primary industry is Specialty Chemicals.

  • Is Okay Pharmaceutical a private or public company?

    Okay Pharmaceutical is a Public company.

  • What is Okay Pharmaceutical’s stock symbol?

    The ticker symbol for Okay Pharmaceutical is 920230.

  • What is the current stock price of Okay Pharmaceutical?

    As of 20-Nov-2026 the stock price of Okay Pharmaceutical is $1.27.

  • What is the current market cap of Okay Pharmaceutical?

    The current market capitalization of Okay Pharmaceutical is $127M.

  • What is Okay Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Okay Pharmaceutical is $46.9M.

  • What is Okay Pharmaceutical’s annual earnings per share (EPS)?

    Okay Pharmaceutical’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process